Bank Of America Corp Forte Biosciences, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$0.46 - $0.78 $121 - $206	265 New	265 $0
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.82 $36 - $78	-96 Reduced 82.05%	21 $0
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.11 $237 - $268	-242 Reduced 67.41%	117 $0
Q1 2023 May 12, 2023	BUY	$0.98 - $1.06 $192 - $207	196 Added 120.25%	359 $0
Q4 2022 Feb 10, 2023	SELL	$0.96 - $28.0 $75 - $2,212	-79 Reduced 32.64%	163 $0
Q3 2022 Nov 14, 2022	SELL	$1.06 - $27.75 $1,303 - $34,132	-1,230 Reduced 83.56%	242 $0
Q2 2022 Aug 12, 2022	SELL	$1.07 - $1.55 $63,489 - $91,970	-59,336 Reduced 97.58%	1,472 $1,000
Q1 2022 May 16, 2022	SELL	$1.21 - $2.24 $2,787 - $5,160	-2,304 Reduced 3.65%	60,808 $89,000
Q4 2021 Feb 08, 2022	BUY	$2.02 - $3.36 $114,594 - $190,612	56,730 Added 888.91%	63,112 $136,000
Q3 2021 Nov 15, 2021	BUY	$2.96 - $36.67 $5,644 - $69,929	1,907 Added 42.61%	6,382 $19,000
Q2 2021 Sep 13, 2021	BUY	$31.5 - $42.5 $140,962 - $190,187	4,475 New	4,475 $150,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.